Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, April 26, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19
admin
-
April 30, 2020
0
Latest Pharma-News
Paradigm Biopharmaceuticals completes Zilosul dosing under FDA’s Expanded Access Program
admin
-
April 30, 2020
0
Latest Pharma-News
Antibodies from llamas could help in the fight against COVID-19
admin
-
April 30, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: Daily Roundup April 29, 2020
admin
-
April 30, 2020
0
Latest Pharma-News
FDA Grants Marketing of New Device for Continuous Dialysis Therapy for Use in Pediatric Patients with Certain Kidney Conditions
admin
-
April 30, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: Daily Roundup April 28, 2020
admin
-
April 29, 2020
0
Latest Pharma-News
ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer
admin
-
April 29, 2020
0
Latest Pharma-News
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Use at an Additional Recommended Dose of 400 mg Every Six Weeks for All Approved Adult Indications
admin
-
April 29, 2020
0
Latest Pharma-News
Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox
admin
-
April 29, 2020
0
Latest Pharma-News
Shionogi Accelerates Development of Potential COVID-19 Treatments and Vaccine
admin
-
April 29, 2020
0
Latest Pharma-News
ViiV Healthcare announces £3 million global fund to research the impact of COVID-19 on the HIV community and fill gaps in prevention, treatment and...
admin
-
April 29, 2020
0
Latest Pharma-News
Can an existing HIV medication slow the spread of COVID-19?
admin
-
April 29, 2020
0
1
...
116
117
118
...
144
Page 117 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024